STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables)

3 Months Ended

Mar. 31, 2019

Share-based Payment Arrangement [Abstract]

Schedule of weighted-average assumptions to estimate the fair values of stock options granted

The following table presents the weighted-average assumptions used to estimate the fair value of the stock options granted during the three months ended March 31, 2019:

Risk Free Interest Rate		2.14	%
Expected Volatility		424.69	%
Expected Life (in years)		5.0
Dividend Yield		0	%
Weighted average estimated fair value of
options during the period	$	0.27

Schedule of stock option activity

Options Outstanding
				Weighted -
				Average		Aggregate
				Remaining		Intrinsic
		Weighted-		Contractual		Value
	Number of	Average		Term		(in 000’s)
	Shares	Exercise Price		(in years)		(1)
Balance as of December 31, 2018	18,613,529	$	0.14
Granted	1,000,000		0.20
Balance March 31, 2019	19,613,529	$	0.14
Exercisable at March 31, 2019	17,121,863	$	0.13		3.6	$	3,203

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s common stock for options that were in-the-money at each respective period. 

Schedule of summary for the activities of unvested stock options

The following table summarizes the activities for the Company’s unvested stock options for the three months ended March 31, 2019:

	Unvested Options
				Weighted -
				Average
				Grant
	Number of Unvested			Date Exercise Price
	Options
Balance December 31, 2018		2,016,666		$	0.18
Granted		1,000,000			0.20
Vested		(525,000	)		0.21
Balance March 31, 2019		2,491,666		$	0.18

Schedule of warrant activity

The following table summarizes the activities for the Company’s warrants for the three months ended March 31, 2019:

	Warrants Outstanding
	Number of Shares		Weighted- Average Exercise Price		Weighted - Average Remaining Contractual Term in years)		Aggregate Intrinsic Value (in 000's) (1)
Balance, December 31, 2018		22,240,833	$	0.31
Granted		-		-
Balance, March 31, 2019		22,240,833	$	0.31		3.5
Exercisable at March 31, 2019		22,240,833	$	0.31		3.5	$	3,387

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.29 for our common stock on March 31, 2019.